Literature DB >> 18599084

Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury.

François Berthiaume1, Laurent Barbe, Yasuji Mokuno, Annette D MacDonald, Rohit Jindal, Martin L Yarmush.   

Abstract

BACKGROUND: Steatosis decreases survival of liver grafts after transplantation due to poorly understood mechanisms. We examined the effect of steatosis on the survival of liver grafts in a rat liver transplantation model and the viability of cultured rat hepatocytes after hypoxia and reoxygenation.
MATERIALS AND METHODS: Rats were fed a choline and methionine-deficient diet to induce hepatic steatosis, and the livers were transplanted into recipient rats after 6 h of cold storage. Cultured hepatocytes were made steatotic by incubation for 3 d in fatty acid-supplemented medium. Hypoxia and reoxygenation were induced by placing the cultures in a 90% N(2)/10% CO(2) atmosphere for 4 h, followed by return to normoxic conditions for 6 h. Hepatocyte viability was assessed by lactate dehydrogenase release and mitochondrial potential staining.
RESULTS: Transplanted steatotic livers exhibited 0% viability compared with 90% for lean liver controls. When donor choline and methionine-deficient diet rats were returned to a normal diet, hepatic fat content decreased while viability of the grafts after transplantation increased. Cultured steatotic hepatocytes generated more mitochondrial superoxide, exhibited a lowered mitochondrial membrane potential, and released significantly more lactate dehydrogenase after hypoxia and reoxygenation than lean hepatocyte controls. When steatotic hepatocytes were defatted by incubating in fatty acid-free medium, they became less sensitive to hypoxia and reoxygenation as the remaining intracellular triglyceride content decreased.
CONCLUSIONS: Hepatic steatosis reversibly decreases viability of hepatocytes after hypoxia and reoxygenation in vitro. The decreased viability of steatotic livers after transplantation may be due to a direct effect of hypoxia and reoxygenation on hepatocytes, and can be reversed by defatting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599084      PMCID: PMC2784014          DOI: 10.1016/j.jss.2007.12.784

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  35 in total

1.  Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisit.

Authors:  A K Chui; L W Shi; A R Rao; D J Verran; D Painter; D Koorey; G W McCaughan; A G Sheil
Journal:  Transplant Proc       Date:  2000-11       Impact factor: 1.066

Review 2.  Hepatic steatosis and liver transplantation current clinical and experimental perspectives.

Authors:  Baburao Koneru; George Dikdan
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

Review 3.  Hepatic ischemia/reperfusion injury--a fresh look.

Authors:  Constantino Fondevila; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Exp Mol Pathol       Date:  2003-04       Impact factor: 3.362

4.  Control analysis of mitochondrial metabolism in intact hepatocytes: effect of interleukin-1beta and interleukin-6.

Authors:  François Berthiaume; Annette D MacDonald; Yoon H Kang; Martin L Yarmush
Journal:  Metab Eng       Date:  2003-04       Impact factor: 9.783

5.  A model for normothermic preservation of the rat liver.

Authors:  Herman Tolboom; Roos Pouw; Korkut Uygun; Yoko Tanimura; Maria-Louisa Izamis; François Berthiaume; Martin L Yarmush
Journal:  Tissue Eng       Date:  2007-08

6.  Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model.

Authors:  Yasuji Mokuno; François Berthiaume; Ronald G Tompkins; Ulysses J Balis; Martin L Yarmush
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

7.  Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.

Authors:  Shinichiro Uchino; Yasuo Yamaguchi; Takashi Furuhashi; Feng-Shan Wang; Jia-Lin Zhang; Kazutoshi Okabe; Shinichi Kihara; Shinwa Yamada; Katsutaka Mori; Michio Ogawa
Journal:  J Surg Res       Date:  2004-07       Impact factor: 2.192

8.  Anti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice.

Authors:  Ryan N Fiorini; Stephen F Shafizadeh; Carmen Polito; David W Rodwell; Gang Cheng; Zachary Evans; Chidan Wan; Sarah Belden; Julia K Haines; Jennifer Birsner; David Lewin; Karen R Wasiluk; David L Dunn; Michael G Schmidt; Kenneth D Chavin
Journal:  Am J Transplant       Date:  2004-10       Impact factor: 8.086

Review 9.  The utility of marginal donors in liver transplantation.

Authors:  Ronald W Busuttil; Koichi Tanaka
Journal:  Liver Transpl       Date:  2003-07       Impact factor: 5.799

10.  Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.

Authors:  Kenneth D Chavin; Ryan N Fiorini; Stephen Shafizadeh; Gang Cheng; Chidan Wan; Zachary Evans; David Rodwell; Carmen Polito; Julia K Haines; G Mark Baillie; Michael G Schmidt
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

View more
  22 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

3.  Glial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers.

Authors:  Sahar Taba Taba Vakili; Roshni Kailar; Khalidur Rahman; Behtash Ghazi Nezami; Simon Musyoka Mwangi; Frank A Anania; Shanthi Srinivasan
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

4.  Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin-stained histology images of human livers.

Authors:  Nir I Nativ; Alvin I Chen; Gabriel Yarmush; Scot D Henry; Jay H Lefkowitch; Kenneth M Klein; Timothy J Maguire; Rene Schloss; James V Guarrera; Francois Berthiaume; Martin L Yarmush
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

Review 5.  Liver defatting: an alternative approach to enable steatotic liver transplantation.

Authors:  N I Nativ; T J Maguire; G Yarmush; D L Brasaemle; S D Henry; J V Guarrera; F Berthiaume; M L Yarmush
Journal:  Am J Transplant       Date:  2012-10-11       Impact factor: 8.086

Review 6.  The dawn of liver perfusion machines.

Authors:  Danielle Detelich; James F Markmann
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

7.  CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model.

Authors:  Zhen-Yu Xiao; Babak Banan; Jianluo Jia; Pamela T Manning; Ronald R Hiebsch; Muthukumar Gunasekaran; Gundumi A Upadhya; William A Frazier; Thalachallour Mohanakumar; Yiing Lin; William C Chapman
Journal:  Liver Transpl       Date:  2015-01-29       Impact factor: 5.799

8.  Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.

Authors:  Nir I Nativ; Gabriel Yarmush; Ashley So; Jeffery Barminko; Timothy J Maguire; Rene Schloss; Francois Berthiaume; Martin L Yarmush
Journal:  Liver Transpl       Date:  2014-07-02       Impact factor: 5.799

9.  Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

10.  Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function.

Authors:  Nir I Nativ; Gabriel Yarmush; Alvin Chen; David Dong; Scot D Henry; James V Guarrera; Kenneth M Klein; Tim Maguire; Rene Schloss; Francois Berthiaume; Martin L Yarmush
Journal:  J Hepatol       Date:  2013-07-19       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.